Document is current

Any future updates will be listed below

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer

Crossref DOI link: https://doi.org/10.1186/s13045-017-0500-5

Published Online: 2017-07-03

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark